GERKEN R JAY
Known title: DirectorCIK: 0001240501
GERKEN R JAY's purchase track record
GERKEN R JAY has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/22/2026 | AFB | $27K | +0.5% | pending | — |
| 5/2/2023 | ASB | $48K | +15.0% | +2.4% | +1.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| AFB | ▲ Buy | Open Market | 2,500 | $27K | 5/22/2026 | View on chart |
| ASB | ▲ Buy | Grant | 44 | $1K | 3/16/2026 | View on chart |
| ASB | ▲ Buy | Grant | 340 | $8K | 3/16/2026 | View on chart |
| ASB | ▲ Buy | Grant | 4,585 | $125K | 2/1/2026 | View on chart |
| ASB | ▲ Buy | Grant | 45 | $1K | 12/15/2025 | View on chart |
| ASB | ▲ Buy | Grant | 307 | $8K | 12/15/2025 | View on chart |
| ASB | ▲ Buy | Grant | 45 | $1K | 9/15/2025 | View on chart |
| ASB | ▲ Buy | Grant | 303 | $8K | 9/15/2025 | View on chart |
| ASB | ▲ Buy | Grant | 340 | $8K | 6/16/2025 | View on chart |
| ASB | ▲ Buy | Grant | 50 | $1K | 6/16/2025 | View on chart |
| ASB | ▲ Buy | Grant | 348 | $8K | 3/17/2025 | View on chart |
| ASB | ▲ Buy | Grant | 51 | $1K | 3/17/2025 | View on chart |
| ASB | ▲ Buy | Grant | 4,972 | $125K | 2/1/2025 | View on chart |
| ASB | ▲ Buy | Grant | 55 | $1K | 12/16/2024 | View on chart |
| ASB | ▲ Buy | Grant | 298 | $8K | 12/16/2024 | View on chart |
| ASB | ▲ Buy | Grant | 63 | $1K | 9/16/2024 | View on chart |
| ASB | ▲ Buy | Grant | 339 | $7K | 9/16/2024 | View on chart |
| ASB | ▲ Buy | Grant | 65 | $1K | 6/17/2024 | View on chart |
| ASB | ▲ Buy | Grant | 355 | $7K | 6/17/2024 | View on chart |
| ASB | ▲ Buy | Grant | 65 | $1K | 3/15/2024 | View on chart |
| ASB | ▲ Buy | Grant | 352 | $7K | 3/15/2024 | View on chart |
| ASB | ▲ Buy | Grant | 5,998 | $125K | 2/1/2024 | View on chart |
| ASB | ▲ Buy | Grant | 332 | $7K | 12/15/2023 | View on chart |
| ASB | ▲ Buy | Grant | 59 | $1K | 12/15/2023 | View on chart |
| ASB | ▲ Buy | Grant | 66 | $1K | 9/15/2023 | View on chart |
| ASB | ▲ Buy | Grant | 377 | $7K | 9/15/2023 | View on chart |
| ASB | ▲ Buy | Grant | 67 | $1K | 6/15/2023 | View on chart |
| ASB | ▲ Buy | Grant | 448 | $8K | 6/15/2023 | View on chart |
| ASB | ▲ Buy | Open Market | 3,000 | $48K | 5/2/2023 | View on chart |
| ASB | ▲ Buy | Grant | 338 | $6K | 3/15/2023 | View on chart |
| ASB | ▲ Buy | Grant | 60 | $1K | 3/15/2023 | View on chart |
| ASB | ▲ Buy | Grant | 5,499 | $125K | 2/1/2023 | View on chart |
| ASB | ▲ Buy | Grant | 290 | $6K | 12/15/2022 | View on chart |
| ASB | ▲ Buy | Grant | 47 | $1K | 12/15/2022 | View on chart |
| ASB | ▲ Buy | Grant | 286 | $6K | 9/15/2022 | View on chart |
| ASB | ▲ Buy | Grant | 47 | $993 | 9/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Barclays Raises ASB Price Target to $35, Maintains Overweight
Barclays has raised its price target for Associated Banc-Corp to $35 while maintaining an Overweight rating. This move aligns with the broader analyst consensus, where the average target is $34.20. The stock is currently trading near its 52-week high, reflecting recent strength compared to some finance peers. Investors are also awaiting the company's third-quarter earnings report scheduled for late October.
Barclays Raises ASB Price Target to $35, Maintains Overweight. Barclays has raised its price target for Associated Banc-Corp to $35 while maintaining an Overweight rating. This move aligns with the broader analyst consensus, where the average target is $34.20. The stock is currently trading near its 52-week high, reflecting recent strength compared to some finance peers. Investors are also awaiting the company's third-quarter earnings report scheduled for late October.